SCHEMBL8092385

SCHEMBL8092385

CCCNC(=O)Nc1ccc(-c2nc(N)cc(C3(S(=O)(=O)c4ccccc4)CC3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 5/20 0.41
PIK3CA P42336 3/20 0.41
CA2 P00918 3/20 0.40
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA4 P22748 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
RORC P51449 1/20 0.40
NAMPT P43490 4/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39
GHSR Q92847 2/20 0.39
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
MTOR P42345 1/20 0.38
PIK3CG P48736 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8083655 0.92 NAMPT (0.43) PIK3CDPIK3CANAMPTMEN1KMT2A
SCHEMBL8089052 0.92 CA2 (0.41) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8099408 0.91 CA2 (0.42) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8091717 0.91 CA2 (0.40) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8083986 0.90 CA2 (0.39) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8089000 0.90 PIK3CD (0.40) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8092406 0.89 PIK3CA (0.41) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8084013 0.89 PIK3CA (0.41) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8083998 0.89 CA2 (0.39) PIK3CDPIK3CACA2CA12CA1
SCHEMBL8100826 0.88 NAMPT (0.40) PIK3CDPIK3CACA2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007748-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 WO disclosed